NCT01470092View on ClinicalTrials.gov

Tibolone and Placebo in Adjunct to Antidepressant Medication for Women With Menopausal Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Menopausal Depression
Interventions
DRUG

Tibolone

Subjects will take 2.5mg of oral Tibolone daily for the duration of the 12 week trial either alone or in adjunct to currently prescribed antidepressant medication.

Trial Locations (1)

3181

The Alfred Hospital, Melbourne

All Listed Sponsors
lead

The Alfred

OTHER

NCT01470092 - Tibolone and Placebo in Adjunct to Antidepressant Medication for Women With Menopausal Depression | Biotech Hunter | Biotech Hunter